Investigational Drug Information for Filibuvir
✉ Email this page to a colleague
What is the drug development status for Filibuvir?
Filibuvir is an investigational drug.
There have been 4 clinical trials for Filibuvir.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2009.
The most common disease conditions in clinical trials are Hepatitis C, Hepatitis, Chronic, and Hepatitis C, Chronic. The leading clinical trial sponsors are Pfizer and [disabled in preview].
Summary for Filibuvir
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 378 |
WIPO Patent Applications | 236 |
Japanese Patent Applications | 24 |
Clinical Trial Progress | Phase 2 (2009-11-01) |
Vendors | 34 |
Recent Clinical Trials for Filibuvir
Title | Sponsor | Phase |
---|---|---|
Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance | Pfizer | Phase 1 |
Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol) | Pfizer | Phase 1 |
A Study To Investigate Safety And Pharmacokinetics Of A Single Dose Of PF-00868554 (Filibuvir) In Japanese Healthy Adult Volunteers | Pfizer | Phase 1 |
Clinical Trial Summary for Filibuvir
Top disease conditions for Filibuvir
Top clinical trial sponsors for Filibuvir
US Patents for Filibuvir
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |